Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06024668 · ClinicalTrials.gov registry record · NA
Simulated Walking With Multiplexing Prism for Field Expansion in Monocular Vision
A NA study of One Eye Blindness and Blind Left Eye, sponsored by Massachusetts Eye and Ear Infirmary.
- Active
- Registry status
- NA
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT06024668 is a NA study of One Eye Blindness and Blind Left Eye that is active but no longer recruiting, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 1 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06024668, a NA study of One Eye Blindness and Blind Left Eye, is active but no longer recruiting, sponsored by Massachusetts Eye and Ear Infirmary.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators will test the efficacy of the prism in improving the detection of colliding pedestrians during a simulated walking task.
Conditions Studied
Interventions
- DEVICE Multiplexing Prism
Study Locations (1)
Massachusetts
- Schepens Eye Research Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-08-04 |
| Est. Completion | 2026-10-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06024668
The ClinicalTrials.gov registry entry for NCT06024668 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with One Eye Blindness appearing as the primary indexed condition, and to 1 intervention - of which Multiplexing Prism is the first listed.
NCT06024668 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06024668 about?
NCT06024668 is a clinical study titled "Simulated Walking With Multiplexing Prism for Field Expansion in Monocular Vision". The investigators are developing an assistive device, known as multiplexing prism that expands the field of view for individuals with acquired monocular vision (loss of an eye). The investigators will test the efficacy of the prism in improving the detection of colliding pedestrians during a simulat...
What is the current status of trial NCT06024668?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1 participants. The study started on 2024-08-04. Estimated completion is 2026-10-28.
What conditions does trial NCT06024668 study?
This clinical trial studies the following conditions: One Eye Blindness, Blind Left Eye, Blind Right Eye.
What interventions are being tested in trial NCT06024668?
The interventions under investigation include: Multiplexing Prism (DEVICE).
Who is sponsoring clinical trial NCT06024668?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06024668 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.